TY - JOUR
T1 - Guidelines on the classification of foot ulcers in people with diabetes (IWGDF 2023 update)
AU - Monteiro-Soares, Matilde
AU - Hamilton, Emma J.
AU - Russell, David A.
AU - Srisawasdi, Gulapar
AU - Boyko, Edward J.
AU - Mills, Joseph L.
AU - Jeffcoate, William
AU - Game, Frances
N1 - Funding Information:
Several external international expert reviewers reviewed our clinical questions, valuated the importance of the clinical outcomes and the final version of our document. We would like to thank, by alphabetical order, Fermin Martinez‐de‐Jesús (Mexico), Kristien van Acker (Belgium), Maimona Mbaye (Senegal), Norina Gavan (Romania), Rui Carvalho (Portugal), Shigeo Kono (Japan), Simone McConnie (Barbados), Stephen Twigg (Australia), and Zahid Miyan (Pakistan). Also, two patient representatives (Jonathan Cohen [United Kingdom] and Rama Krishnan [India]), reviewed our clinical questions and valued the importance of the clinical outcomes for which we are grateful. Matilde Monteiro‐Soares' work was financed by national funds through FCT Fundação para a Ciência e a Technology, I.P., within the scope of the project “RISE ‐ LA/P/0053/2020. Emma J. Hamilton was supported by a Clinician Research Fellowship from the Raine Medical Research Foundation. David A. Russell was supported through an Advanced Fellowship from the National Institute for Health and Care Research (NIHR300633). VA Puget Sound provided support for Edward Boyko's participation in this work.
Funding Information:
Production of the 2023 IWGDF Guidelines was supported by unrestricted grants from: Advanced Oxygen Therapy Inc., Essity, Mölnlycke, Reapplix, and Urgo Medical. These sponsors had no communication relating to the content of the systematic reviews or these guidlines with the members of the working groups during the writing of the guideline and have not seen the guideline or any documentation relating to the guideline prior to publication. Full conflict of interest of all authors can be found online at https://iwgdfguidelines.org .
Publisher Copyright:
© 2023 John Wiley & Sons Ltd.
PY - 2024/3
Y1 - 2024/3
N2 - Background: This publication represents a scheduled update of the 2019 guidelines of the International Working Group of the Diabetic Foot (IWGDF) addressing the use of systems to classify foot ulcers in people with diabetes in routine clinical practice. The guidelines are based on a systematic review of the available literature that identified 28 classifications addressed in 149 articles and, subsequently, expert opinion using the GRADE methodology. Methods: First, we have developed a list of classification systems considered as being potentially adequate for use in a clinical setting, through the summary of judgements for diagnostic tests, focussing on the usability, accuracy and reliability of each system to predict ulcer-related complications as well as use of resources. Second, we have determined, following group debate and consensus, which of them should be used in specific clinical scenarios. Following this process, in a person with diabetes and a foot ulcer we recommend: (a) for communication among healthcare professionals: to use the SINBAD (Site, Ischaemia, Bacterial infection, Area and Depth) system (first option) or consider using WIfI (Wound, Ischaemia, foot Infection) system (alternative option, when the required equipment and level of expertise is available and it is considered feasible) and in each case the individual variables that compose the systems should be described rather than a total score; (b) for predicting the outcome of an ulcer in a specific individual: no existing system could be recommended; (c) for characterising a person with an infected ulcer: the use of the IDSA/IWGDF classification (first option) or consider using the WIfI system (alternative option, when the required equipment and level of expertise is available and it is considered as feasible); (d) for characterising a person with peripheral artery disease: consider using the WIfI system as a means to stratify healing likelihood and amputation risk; (e) for the audit of outcome(s) of populations: the use of the SINBAD score. Conclusions: For all recommendations made using GRADE, the certainty of evidence was judged, at best, as being low. Nevertheless, based on the rational application of current data this approach allowed the proposal of recommendations, which are likely to have clinical utility.
AB - Background: This publication represents a scheduled update of the 2019 guidelines of the International Working Group of the Diabetic Foot (IWGDF) addressing the use of systems to classify foot ulcers in people with diabetes in routine clinical practice. The guidelines are based on a systematic review of the available literature that identified 28 classifications addressed in 149 articles and, subsequently, expert opinion using the GRADE methodology. Methods: First, we have developed a list of classification systems considered as being potentially adequate for use in a clinical setting, through the summary of judgements for diagnostic tests, focussing on the usability, accuracy and reliability of each system to predict ulcer-related complications as well as use of resources. Second, we have determined, following group debate and consensus, which of them should be used in specific clinical scenarios. Following this process, in a person with diabetes and a foot ulcer we recommend: (a) for communication among healthcare professionals: to use the SINBAD (Site, Ischaemia, Bacterial infection, Area and Depth) system (first option) or consider using WIfI (Wound, Ischaemia, foot Infection) system (alternative option, when the required equipment and level of expertise is available and it is considered feasible) and in each case the individual variables that compose the systems should be described rather than a total score; (b) for predicting the outcome of an ulcer in a specific individual: no existing system could be recommended; (c) for characterising a person with an infected ulcer: the use of the IDSA/IWGDF classification (first option) or consider using the WIfI system (alternative option, when the required equipment and level of expertise is available and it is considered as feasible); (d) for characterising a person with peripheral artery disease: consider using the WIfI system as a means to stratify healing likelihood and amputation risk; (e) for the audit of outcome(s) of populations: the use of the SINBAD score. Conclusions: For all recommendations made using GRADE, the certainty of evidence was judged, at best, as being low. Nevertheless, based on the rational application of current data this approach allowed the proposal of recommendations, which are likely to have clinical utility.
KW - audit
KW - classification
KW - clinical decision-making
KW - diabetic foot
KW - foot ulcer
KW - outcome prediction
KW - professional communication
UR - http://www.scopus.com/inward/record.url?scp=85158013446&partnerID=8YFLogxK
U2 - 10.1002/dmrr.3648
DO - 10.1002/dmrr.3648
M3 - Article
C2 - 37179483
AN - SCOPUS:85158013446
SN - 1520-7552
VL - 40
JO - Diabetes/Metabolism Research and Reviews
JF - Diabetes/Metabolism Research and Reviews
IS - 3
M1 - e3648
ER -